ISSUES OF ANTICOAGULANT TREATMENT MANAGEMENT
- Authors: Zateyshchikov DA1, Isaeva MY.2
-
Affiliations:
- МЦ Управления Делами Президента России
- ФНКЦ ФМБА России
- Issue: Vol 3, No 3 (2012)
- Pages: 51-62
- Section: Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/8240
- DOI: https://doi.org/10.17816/clinpract3351-62
- ID: 8240
Cite item
Full Text
Abstract
The review provides information about various aspects of anticoagulant treatment organization. The recommendations concerning the organization of a specialized anticoagulant service are discussed. The rules of patient education, the choice of anticoagulant dosage control are described. Authors provide data of the cost-effectiveness of anticoagulants.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
D A Zateyshchikov
МЦ Управления Делами Президента России
Email: dz@bk.ru
профессор кафедры кардиологии и общей терапии МЦ Управления Делами Президента, д.м.н.
M Yu Isaeva
ФНКЦ ФМБА Россииврач-кардиолог КДЦ ФНКЦ ФМБА России, к.м.н.
References
- Stowasser D. A, MO'Leary K. Understanding the Medicines Management Pathway. Journal of Pharmacy Practice and Research 2004;Volume 34, :293-296.
- Bajorek B. A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks. Therapeutic Advances in Drug Safety 2011;2:45-58.
- Hall D, Buchanan J, Helms B, et al. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care. Pharmacotherapy 2011;31:686-694.
- Сычев Д.А., Гаврисюк Е.В., Поликарпова О.А. Методология создания и функционирования центров персонализированной антикоагулянтной терапии: взаимодействие лабораторных и клинических методов повышения эффективности и безопасности фармакотерапии. Справочник заведующего клинико-диагностической лабораторией, 2011;1 3-5.
- Hendriks JM, de Wit R, Crijns HJ, et al. Nurseled care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. European heart journal 2012.
- Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis 2003;15:213-216.
- Okumura K, Komatsu T, Yamashita T, et al. Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. - A multicenter study of its status and infuential factors. Circulation journal: official journal of the Japanese Circulation Society 2011;75:2087-2094.
- Lind M, Fahlen M, Kosiborod M, et al. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation. Thromb Res 2012;129:32-35.
- Rose AJ, Hylek EM, Berlowitz DR, et al. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care. Circulation Cardiovascular quality and outcomes 2011; 4:276-282.
- Wieloch M, Sjalander A, Frykman V, et al. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. European heart journal 2011; 32: 2282- 2289.
- Indicators for Quality Use of Medicines in Australian Hospitals: NSW Therapeutic Advisory Group. http://wwwciaphealthnswgovau/nswtag/ 2007.
- Ghate SR, Biskupiak JE, Ye X, et al. Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis. Ann Pharmacother 2011; 45:701-712.
- Fitzmaurice DA, Gardiner C, Kitchen S, et al. An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. British journal of haematology 2005;131:156-165.
- Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012;379:322-334.
- Matchar DB, Jacobson A, Dolor R, et al. Effect of home testing of international normalized ratio on clinical events. The New England journal of medicine 2010;363:1608-1620.
- Bloomfield HE, Krause A, Greer N, et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med 2011;154:472-482.
- Plesch W, Wolf T, Breitenbeck N, et al. Results of the performance verification of the CoaguChek XS system. Thromb Res 2008;123:381-389.
- Sobieraj-Teague M, Daniel D, Farrelly B, et al. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting. Thromb Res 2009;123:909-913.
- Solvik UO, Petersen PH, Monsen G, et al. Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clin Chem 2010; 56: 1618-1626.
- Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. British journal of haematology 2011;154:311-324.
- Platt AB, Localio AR, Brensinger CM, et al. Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest 2010;137:883-889.
- Bushnell CD, Olson DM, Zhao X, et al. Secon- dary preventive medication persistence and adherence 1 year after stroke. Neurology 2011;77:1182-1190.
- Белоусов Ю.Б., Явелов И.С., Белоусов Д.Ю., Афанасьева Е.В. Анализ прямых затрат, ассоциированных с применением варфарина у пациентов с фибрилляцией предсердий. Рациональная Фармакотерапия в Кардиологии 2011;7:561-566.
- Atay JK, Fiumara K, Piazza G, Fanikos J, Goldhaber SZ. Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18:181-184.
- Ягудина Р.И., Куликов А.Ю., Тихомирова А.В. Возможность переноса фармакоэкономических данных из страны в страну. Фармакоэкономика 2009;2:8-18.
- Белоусов Ю.Б., Мареев В.Ю., Явелов И.С., Белоусов Д.Ю. Фармакоэкономический анализ эффективности дабигатрана этексилата у пациентов с неклапанной фибрилляцией предсердий. Кардиология 2012;51:44-51.
- Белоусов Ю.Б., Мареев В.Ю., Явелов И.С., Белоусов Д.Ю.Клинико-экономический анализ эффективности дабигатрана этексилата в сравнении с варфарином в аспекте профилактики сердечно-сосудистых осложнений у пациентов с неклапанной фибрилляцией предсердий. Рациональная фармакотерапия в кардиологии 2012;8:37-44.
- Jacobs JW, Bernhard MR, Delgado A, Strain JJ. Screening for organic mental syndromes in the medically ill. Ann Intern Med 1977;86:40-46.
- McHorney C, Ware J, Raczek A. The MOS 36- Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263